RSI Oversold Bounce Stocks — Valuation View · Biological Products, (No Diagnostic Substances)

5 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Valuation columns. Filtered to Biological Products, (No Diagnostic Substances). Updated 22 h ago

1–5 of 5


GLUE	Monte Rosa Therapeutics, Inc.	$1.2B	-7.62	—	2.52	13.62	—	14.39	+1.12%	38K
GRML	Greenland Mines Ltd	$715M	-32.84	—	12.35	76.86	—	4.50	-7.31%	22K
SCLX	Scilex Holding Co	$45M	-0.10	1.43	—	79.68	—	5.31	-0.56%	2K
PMCB	PharmaCyte Biotech, Inc.	$5M	-0.33	—	0.19	0.30	—	0.49	+1.62%	800
VIVS	VivoSim Labs, INC.	$4M	-0.30	31.25	—	2.45	—	0.28	-1.01%	8K

Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials reflect the latest reported annual period. Informational only — not financial advice.